76 related articles for article (PubMed ID: 19887879)
21. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
[TBL] [Abstract][Full Text] [Related]
22. Recoverin: a potent uveitogen for the induction of photoreceptor degeneration in Lewis rats.
Adamus G; Ortega H; Witkowska D; Polans A
Exp Eye Res; 1994 Oct; 59(4):447-55. PubMed ID: 7859820
[TBL] [Abstract][Full Text] [Related]
23. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
24. Aberrantly expressed recoverin is functionally associated with G-protein-coupled receptor kinases in cancer cell lines.
Miyagawa Y; Ohguro H; Odagiri H; Maruyama I; Maeda T; Maeda A; Sasaki M; Nakazawa M
Biochem Biophys Res Commun; 2003 Jan; 300(3):669-73. PubMed ID: 12507501
[TBL] [Abstract][Full Text] [Related]
25. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
27. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
Andrews P; Zhao X; Allen J; Li F; Chang M
Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal assignment of the human gene for the cancer-associated retinopathy protein (recoverin) to chromosome 17p13.1.
McGinnis JF; Austin B; Klisak I; Heinzmann C; Kojis T; Sparkes RS; Bateman JB; Lerious V
J Neurosci Res; 1995 Feb; 40(2):165-8. PubMed ID: 7745609
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors.
Montanari M; Boninsegna A; Faraglia B; Coco C; Giordano A; Cittadini A; Sgambato A
J Cell Physiol; 2005 Jan; 202(1):215-22. PubMed ID: 15389519
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival of a patient with small cell lung cancer associated with cancer-associated retinopathy.
Kobayashi M; Ikezoe T; Uemura Y; Ueno H; Taguchi H
Lung Cancer; 2007 Sep; 57(3):399-403. PubMed ID: 17397962
[TBL] [Abstract][Full Text] [Related]
33. Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy.
Saito W; Kase S; Yoshida K; Ohguro H; Yokoi M; Iwaki H; Ohno S
Am J Ophthalmol; 2005 Nov; 140(5):942-5. PubMed ID: 16310487
[TBL] [Abstract][Full Text] [Related]
34. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.
Ito S; Kawano Y; Katakura H; Takenaka K; Adachi M; Sasaki M; Shimizu K; Ikenaka K; Wada H; Tanaka F
Lung Cancer; 2006 Jan; 51(1):79-88. PubMed ID: 16225959
[TBL] [Abstract][Full Text] [Related]
35. Recoverin as a cancer-retina antigen.
Bazhin AV; Schadendorf D; Philippov PP; Eichmüller SB
Cancer Immunol Immunother; 2007 Jan; 56(1):110-6. PubMed ID: 16444517
[TBL] [Abstract][Full Text] [Related]
36. G-Protein-Coupled Receptors Mediate Modulations of Cell Viability and Drug Sensitivity by Aberrantly Expressed Recoverin 3 within A549 Cells.
Ichioka H; Hirohashi Y; Sato T; Furuhashi M; Watanabe M; Ida Y; Hikage F; Torigoe T; Ohguro H
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614215
[TBL] [Abstract][Full Text] [Related]
37. Cancer-retina antigens -- a new group of tumor antigens.
Golovastova MO; Bazhin AV; Philippov PP
Biochemistry (Mosc); 2014 Aug; 79(8):733-9. PubMed ID: 25365483
[TBL] [Abstract][Full Text] [Related]
38. Expression of Ca-binding protein recoverin in normal, surviving, and regenerating retina of Pleurodeles waltl adult triton.
Grigoryan EN; Bazhin AV; Krasnov MS; Philippov PP
Bull Exp Biol Med; 2009 Jul; 148(1):155-62. PubMed ID: 19902119
[TBL] [Abstract][Full Text] [Related]
39. GCAP1, Rab6, and HSP27: Novel Autoantibody Targets in Cancer-Associated Retinopathy and Autoimmune Retinopathy.
Yang S; Dizhoor A; Wilson DJ; Adamus G
Transl Vis Sci Technol; 2016 May; 5(3):1. PubMed ID: 27152249
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies against the Ca(2+)-binding protein recoverin in blood sera of patients with various oncological diseases.
Savchenko MS; Goncharskaia MA; Skorikova EE; Eichmüller SB; Kushlinsky NE; Bazhin AV; Philippov PP
Oncol Lett; 2012 Feb; 3(2):377-382. PubMed ID: 22740915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
